Results 181 to 190 of about 38,793 (285)
RNA-Targeting CRISPR–Cas Systems and Their Applications [PDF]
Michał Burmistrz +2 more
openalex +1 more source
Advancements in CRISPR/Cas systems for disease treatment. [PDF]
Xu Y, Le H, Wu Q, Wang N, Gong C.
europepmc +1 more source
In this manuscript, protein disulfide isomerase A3 (PDIA3) is identified as a key factor mediating the susceptibility of ferroptosis in GBM. Inhibition of PDIA3 enhances IKE or cystine starvation‐induced ferroptosis in GBM cells by resulting in the accumulation of lipid peroxidation and a reduction in GSH level.
Jie Zhang +19 more
wiley +1 more source
Characterization of CRISPR‐Cas systems in the Ralstonia solanacearum species complex [PDF]
André da Silva Xavier +7 more
openalex +1 more source
Acquisition of Spacers from Foreign Prokaryotic Genomes by CRISPR-Cas Systems in Natural Environments. [PDF]
Sures K +9 more
europepmc +1 more source
By integrating biomechanical and epigenetic cues, the evolutionarily conserved TPM1 super‐enhancer drives myogenesis via TEAD4‐mediated chromatin looping. This mechanism produces species‐specific outputs (linear TPM1 mRNA in mice and CircTPM1 in bovine) that activate PI3K/AKT mechanotransduction and the MYH10/MYL3 axis to execute cytoskeletal ...
Ruimen Zhang +27 more
wiley +1 more source
Comparative analysis of CRISPR-Cas systems of <em>Yersinia pestis</em> and <em>Escherichia coli</em> strains [PDF]
Uchenna N. Eze +4 more
openalex +1 more source
Discarded diversity: novel megaphages, auxiliary metabolic genes, and virally encoded CRISPR-Cas systems in landfills. [PDF]
George NA +3 more
europepmc +1 more source
A mutually exclusive screening system is established to identify negative regulators of highly plastic genes. Dual specificity phosphatase (DUSP9) is a novel negative regulatory molecule of PD‐L1 by dephosphorylating STAT3, and acts as a target molecule in combination with PD‐1 antibody for tumor immunotherapy and a new clinical biomarker for ...
Yuzhe Hu +9 more
wiley +1 more source

